Clinical findings of hyperechoic substantia nigra in patients with Parkinson's disease

被引:1
|
作者
Fan, Yongyan [1 ,2 ]
Ma, Jianjun [1 ,2 ,3 ,4 ]
Yang, Dawei [1 ,2 ]
Li, Xiaohuan [1 ,2 ]
Liang, Keke [2 ,3 ]
She, Zonghan [1 ,2 ]
Qi, Xuelin [1 ,2 ]
Shi, Xiaoxue [1 ,2 ,3 ]
Gu, Qi [1 ,2 ,3 ]
Zheng, Jinhua [1 ,2 ,3 ]
Li, Dongsheng [1 ,2 ,3 ]
机构
[1] Zhengzhou Univ, Peoples Hosp, Dept Neurol, Zhengzhou, Peoples R China
[2] Henan Prov Peoples Hosp, Dept Neurol, Zhengzhou, Peoples R China
[3] Henan Univ, Peoples Hosp, Dept Neurol, Zhengzhou, Peoples R China
[4] Zhengzhou Univ, Peoples Hosp, Dept Neurol, Zhengzhou 450003, Peoples R China
关键词
biomarker; hyperechoic substantia nigra; iron deposition; microglial activation; Parkinson's disease; TRANSCRANIAL BRAIN SONOGRAPHY; IRON ACCUMULATION; URIC-ACID; DIFFERENTIAL-DIAGNOSIS; TASK-FORCE; HYPERECHOGENICITY; ECHOGENICITY; SENSITIVITY; SCALE; REPRODUCIBILITY;
D O I
10.1111/ejn.16308
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study aims to analyse hyperechoic substantia nigra (HSN) characteristics and the correlation of HSN with clinical features and blood biomarkers in patients with Parkinson's disease (PD). Transcranial sonography (TCS) evaluations of the substantia nigra (SN) were performed in 40 healthy controls and 71 patients with PD, including patients with SN hyperechogenicity (SN+) and those with normal SN echogenicity (SN-). Evaluation of motor and non-motor symptoms was assessed by a series of rating scales. The uricase method was used to determine serum uric acid (UA) levels, and enzyme-linked immunosorbent assay (ELISA) was used to measure plasma interleukin (IL)-1 beta levels. TCS showed 92.50% specificity and 61.97% sensitivity in differentiating PD patients from controls. The area of SN+ contralateral to the side of initial motor symptoms (SNcontra) was larger than that ipsilateral to the side of initial motor symptoms (SNipsi). The PDSN+ group had lower Argentine Hyposmia Rating Scale (AHRS) scores and UA levels than the PDSN- group. Binary logistic regression analysis revealed that AHRS scores and UA levels could be independent predictors for HSN. The larger SN echogenic area (SNL) sizes positively correlated with plasma IL-1 beta levels in PD patients with SN+. The present study provides further evidence of the potential of SN echogenicity as an imaging biomarker for PD diagnosis. PD patients with HSN have more severe non-motor symptoms of hyposmia. HSN in PD patients is related to the mechanism of abnormal iron metabolism and microglial activation. Transcranial sonography (TCS) has potential as a tool for Parkinson's disease (PD) diagnosis. Hyperechoic substantia nigra (HSN) is a stable marker during the course of PD and does not reflect disease progression. PD patients with HSN have severer non-motor symptoms of hyposmia. HSN in PD patients is related to the mechanism of abnormal iron metabolism and microglial activation. image
引用
收藏
页码:2702 / 2714
页数:13
相关论文
共 50 条
  • [21] Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease
    Huang, P.
    Zhou, H. Y.
    Chen, S. D.
    MOVEMENT DISORDERS, 2018, 33 : S647 - S648
  • [22] Quantitative proteomic analysis of substantia nigra in patients with Parkinson's disease
    Licker, V.
    Dayon, L.
    Turck, N.
    Cote, M.
    Rodrigo, N.
    Hochstrasser, D. F.
    Sanchez, J. -C.
    Burkhard, P. R.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S157 - S157
  • [23] Substantia Nigra Echogenicity Signal Correlated with Clinical Features in Patients with Parkinson's Disease in Xinjiang
    Wei, Rurui
    Zhang, Yan
    Li, Peishan
    Xu, Zeheng
    Zhang, La
    He, Yan
    Wu, Qinfen
    Shi, Youcai
    Yuan, Yang
    Aisha, Abudula
    PARKINSONS DISEASE, 2023, 2023
  • [24] ANALYSIS OF CLINICAL CHARACTERISTICS OF SUBSTANTIA NIGRA HYPERECHOGENICITY ON DE NOVO PATIENTS WITH PARKINSON'S DISEASE
    Li, Y.
    Liu, W.
    Liu, B.
    Zhao, M.
    Xie, M.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E52 - E52
  • [25] Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease
    Ruprecht-Döerfler, P
    Berg, D
    Tucha, O
    Benz, P
    Lange, KW
    Becker, G
    MOVEMENT DISORDERS, 2002, 17 : S173 - S173
  • [26] Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease
    Ruprecht-Dörfler, P
    Berg, D
    Tucha, O
    Benz, P
    Meier-Meitinger, M
    Alders, GL
    Lange, KW
    Becker, G
    NEUROIMAGE, 2003, 18 (02) : 416 - 422
  • [27] Organochlorine insecticides in substantia nigra in Parkinson's disease
    Corrigan, FM
    Wienburg, CL
    Shore, RF
    Daniel, SE
    Mann, D
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A, 2000, 59 (04): : 229 - 234
  • [28] Ultrasonography of substantia nigra (SN) in Parkinson's disease
    Ressner, P.
    Skoloudik, D.
    Kanovsky, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 81 - 82
  • [29] FETAL SUBSTANTIA NIGRA GRAFTS FOR PARKINSON′S DISEASE
    吴承远
    鲍秀峰
    张庆林
    李福增
    山东医科大学学报, 1993, (03) : 264 - 270
  • [30] Echogenicity of the substantia nigra region in Parkinson's disease
    Bar-Seng-Shu, Edson
    Almeida, Kelson James
    de Andrade, Daniel Ciampi
    Fonoff, Erich Talamoni
    Teixeira, Manoel Jacobsen
    Barbosa, Egberto Reis
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2012, 70 (02) : 153 - 154